Exosomal MicroRNAs as Potential Biomarkers in Neuropsychiatric Disorders

Author(s):  
Gabriel R. Fries ◽  
Joao Quevedo
2019 ◽  
Vol 42 ◽  
Author(s):  
Nicole M. Baran

AbstractReductionist thinking in neuroscience is manifest in the widespread use of animal models of neuropsychiatric disorders. Broader investigations of diverse behaviors in non-model organisms and longer-term study of the mechanisms of plasticity will yield fundamental insights into the neurobiological, developmental, genetic, and environmental factors contributing to the “massively multifactorial system networks” which go awry in mental disorders.


Author(s):  
Olena A. Shepel ◽  
Tetyana Yu. Voznesenska ◽  
Taras V. Blashkiv ◽  
Roman I. Yanchii

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 1884-P
Author(s):  
YAN MA ◽  
YAN WANG ◽  
XIN WANG ◽  
LONGYAN YANG ◽  
JIANAN LANG ◽  
...  

2020 ◽  
Vol 28 (3) ◽  
pp. 399-405
Author(s):  
Fabrizio Fontana ◽  
Olga A. Babenko

Aim of this letter is to attract the attention of journal readers to the study of exosomes as an important direction in the development of Oncology, in particular, in the diagnosis and treatment of prostate cancer. Exosomes are produced by tumor cells and regulate proliferation, metastasis, and the development of chemoresistance. Their extraction from biological fluids allows further use of these vesicles as potential biomarkers of prostate cancer. In the future, exosomes can be successfully used in the delivery of drugs and other anti-tumor substances to cancer cells.


Sign in / Sign up

Export Citation Format

Share Document